🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
Primary Objectives: * Part A: To evaluate the safety and tolerability of s...
Status
Terminated
Location
Fox Chase Cancer Center Site Number : 8400004
Start Date
2021-09-09
Trial ID
NCT04661033
Treatments Being Tested
This is a randomized, multicenter, Phase 3, open-label study evaluating sub...
Status
Active Not Recruiting
Location
Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028
Start Date
2022-06-23
Trial ID
NCT05405166
This phase I trial studies the side effects of isatuximab and to see how we...
Status
Active Not Recruiting
Location
University of California
Start Date
2021-04-28
Trial ID
NCT04754945
Treatments Being Tested
This is an open-label phase 2 study of elranatamab in combination with isat...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-08-14
Trial ID
NCT06832865
Treatments Being Tested
* This is a multi-center, open-label, Phase 2 treatment extension study in ...
Status
Enrolling By Invitation
Location
Washington University- Site Number : 8400001
Start Date
2023-04-05
Trial ID
NCT05669989
Primary Objective: -To demonstrate the benefit of isatuximab in combinatio...
Status
Active Not Recruiting
Location
Investigational Site Number: 8400006
Start Date
2017-12-07
Trial ID
NCT03319667
Treatments Being Tested